CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 328,176 shares at $22.99 ($7.5M) on 2016-12-16, disclosed to the SEC on 2016-12-20.
Open-market purchase of $7.5M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.99 | 1,330 | $31K | 0.4% |
| 2 | $22.99 | 7,990 | $184K | 2.4% |
| 3 | $22.99 | 7,990 | $184K | 2.4% |
| 4 | $22.99 | 20,033 | $461K | 6.1% |
| 5 | $22.99 | 20,033 | $461K | 6.1% |
| 6 | $22.99 | 29,040 |
| $668K |
| 8.8% |
| 7 | $22.99 | 29,040 | $668K | 8.8% |
| 8 | $22.99 | 42,110 | $968K | 12.8% |
| 9 | $22.99 | 42,110 | $968K | 12.8% |
| 10 | $22.99 | 64,250 | $1.5M | 19.6% |
| 11 | $22.99 | 64,250 | $1.5M | 19.6% |
| Total | $22.99 avg | 328,176 | $7.5M | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |